AGP Executive Report
Last update: 9 hours agoForeign Investment Flows: Foreign investors returned to net buying in Malaysia, adding RM11.1m after a prior week of selling, with financial services, healthcare and transport/logistics leading inflows. Policy & Markets: France broadened foreign investment screening, lowering the trigger to 10% for acquisitions in sensitive sectors to close EU-listed loopholes. Regulation Watch: Robinhood secured UK FCA crypto registration ahead of the new authorization regime, positioning it to operate under current anti-money-laundering rules. Deal Sentiment: AstraZeneca shares slid as investors questioned the logic of reported merger talks with Bristol Myers Squibb, despite potential scale benefits. Investment Blueprint: RHB IB expects Iskandar Malaysia’s SEZ blueprint and master plan to be unveiled by year-end, with the Johor Bahru–Singapore RTS Link due in December and continued demand from manufacturing and data centers. Legal & Investor Risk: A wave of securities class actions and investigations hit major public names, including Microsoft, Intuit, Rackspace, Planet Fitness, Zillow and others, with multiple lead-plaintiff deadlines in August and September. Corporate Update: Krystal Biotech reported 2Q results for VYJUVEK, highlighting strong revenue growth and a cash-and-investments balance of $1.1b. Crypto Leverage Warning: A trader’s repeated liquidations on an S&P 500 perpetual contract underscored how leverage can quickly erase capital even as activity remains high.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
